122 related articles for article (PubMed ID: 6125356)
1. The disposition and metabolism of 14C-tiaramide . HCl in man.
Klunk LJ; Riska PS; Maynard DE
Drug Metab Dispos; 1982; 10(3):241-5. PubMed ID: 6125356
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution, excretion and metabolism of tiaramide hydrochloride: a new anti-inflammatory drug.
Noda K; Noguchi H; Okui M; Tada K; Morimoto Y
Arzneimittelforschung; 1972 Apr; 22(4):732-43. PubMed ID: 4626080
[No Abstract] [Full Text] [Related]
5. Metabolism and excretion of ropivacaine in humans.
Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
[TBL] [Abstract][Full Text] [Related]
6. Terminal N-sulphoconjugation of an alicyclic amine (piperazine), identified as a new metabolite of tiaramide in mouse and rat.
Iwasaki K; Shiraga T; Noda K; Tada K; Noguchi H
Xenobiotica; 1983 May; 13(5):273-8. PubMed ID: 6636823
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers.
Polsky-Fisher SL; Vickers S; Cui D; Subramanian R; Arison BH; Agrawal NG; Goel TV; Vessey LK; Murphy MG; Lasseter KC; Simpson RC; Vega JM; Rodrigues AD
Drug Metab Dispos; 2006 Jun; 34(6):1004-11. PubMed ID: 16510541
[TBL] [Abstract][Full Text] [Related]
8. The disposition and metabolism of [14C]fluconazole in humans.
Brammer KW; Coakley AJ; Jezequel SG; Tarbit MH
Drug Metab Dispos; 1991; 19(4):764-7. PubMed ID: 1680653
[TBL] [Abstract][Full Text] [Related]
9. Disposition and metabolism of radiolabeled casopitant in humans.
Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
[TBL] [Abstract][Full Text] [Related]
10. The disposition and metabolic fate of 14C-cibenzoline in man.
Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation and elimination of 14C-flecainide acetate in humans.
McQuinn RL; Quarfoth GJ; Johnson JD; Banitt EH; Pathre SV; Chang SF; Ober RE; Conard GJ
Drug Metab Dispos; 1984; 12(4):414-20. PubMed ID: 6148206
[TBL] [Abstract][Full Text] [Related]
12. Urinary metabolite profile of tiaramide in man and in some animal species.
Noguchi H; Tada K; Iwasaki K
Xenobiotica; 1982 Apr; 12(4):211-20. PubMed ID: 7113257
[TBL] [Abstract][Full Text] [Related]
13. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
14. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects.
Hoffmann M; DeMaio W; Jordan RA; Talaat R; Harper D; Speth J; Scatina J
Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869
[TBL] [Abstract][Full Text] [Related]
15. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers.
Paulson SK; Hribar JD; Liu NW; Hajdu E; Bible RH; Piergies A; Karim A
Drug Metab Dispos; 2000 Mar; 28(3):308-14. PubMed ID: 10681375
[TBL] [Abstract][Full Text] [Related]
17. The disposition and metabolism of 14C-oxprenolol.HCl in man.
Dieterle W; Faigle JW; Küng W; Theobald W
Xenobiotica; 1986 Feb; 16(2):181-91. PubMed ID: 3515777
[TBL] [Abstract][Full Text] [Related]
18. [Comparative metabolic studies on [14C]-labelled acemetacin and indometacin in rats (author's transl)].
Surborg KH
Arzneimittelforschung; 1980; 30(8A):1384-91. PubMed ID: 7191305
[TBL] [Abstract][Full Text] [Related]
19. Disposition and metabolic fate of 14C-quazepam in man.
Zampaglione N; Hilbert JM; Ning J; Chung M; Gural R; Symchowicz S
Drug Metab Dispos; 1985; 13(1):25-9. PubMed ID: 2858372
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
